Abstract Intra-vesicular Bacillus Calmette-Gue´rin (BCG) immuno-therapy is a cornerstone in the treatment of superficial bladder carcinoma. However, it can rarely cause BCG-osis, a systemic infection, potentially fatal. A case of a 73 year old man, diagnosed with superficial urothelial bladder carcinoma five months ago, who died with clinical features of septic shock one day after BCG therapeutic maintenance infusion, is presented. The cause of death, BCG-osis, was revealed during autopsy. 
Introduction
BCG (Bacillus Calmette-Gue´rin) is prepared from a strain of the attenuated live bovine bacillus, Mycobacterium bovis. 1, 2 Additional to its use, as a vaccine for the prevention of tuberculosis, BCG has therapeutic effects on several conditions such as leprosy, 3 Buruli ulcer 4 and several carcinomas. BCG has been reported for its potency against lung, stomach and colorectal cancer, melanoma, ovarian carcinoma and bladder tumors. [5] [6] [7] [8] However, if BCG is accidentally given to an immunocompromised patient, it can cause disseminated or life-threatening infection. 2, 9 BCG immunotherapy, is a safe method [10] [11] [12] used against recurrence and progression of superficial urothelial carcinoma of the bladder. 13 It affects both healthy urothelial cells and tumor cells [14] [15] by inducing a localized type IV hypersensitivity reaction in the bladder mucosa. It has been postulated that epitopes of BCG bacillus are presented as antigens on the surface of tumor cells, thus initiating cell to cell cytotoxicity. 15 According to EAU Guidelines non-muscle-invasive urothelial bladder carcinoma patients are stratified in low, intermediate and high risk groups in order to estimate their prognosis and indicate an adequate treatment regimen. 16 BCG immunotherapy is indicated, in intermediate and high risk tumors. Several studies have proved that it prevents tumor recurrence and progression after transurethral resection (TUR) and that is more effective than TUR with adjuvant chemotherapy. 16 The usual induction protocol for BCG instillation is the six-weekly one, followed by a maintenance protocol, if needed. 17 However, BCG immunotherapy has a greater complication incidence than intra-vesical chemotherapy and some of these complications, although rare, can be serious. 10, 16 BCG-osis is one of them.
The absolute contra-indications of BCG intra-vesical instillation are: recent TUR (less than fourteen days), macroscopic hematuria, urinary tract infection and traumatic bladder catheterization. 6, 16 We present a case of fatal BCG-osis revealed in autopsy.
Case report
The deceased, a 73 year old white man, was a chronic smoker who had suffered a myocardial infarct thirty-eight years ago. He was under anti-hypertensive medication with a combination of an angiotensin converting enzyme inhibitor plus a thiazide diuretic and acetylsalicylic acid. There was no history of previous pulmonary disease or immunodeficiency state. He was diagnosed with superficial papillary urothelial bladder carcinoma 5 months ago, after a TUR. Following this diagnosis, he underwent intra-vesicular BCG immunotherapy, based on a weekly and then monthly instillation protocol. He had been reporting low fever (<38°C) after each therapeutic session, which remised without medication.
After, his last intra-vesical BCG infusion, he presented with high fever, fatigue, oliguria, and dysuria. The clinical records didn't state any complication during the last instillation procedure. Due to a progressively deteriorating general condition, and the presence of an abdominal skin rash, he was transferred to our hospital the following day. Upon arrival, he was already septic, and despite the administration of adrenaline, broad spectrum antibiotics and corticosteroids, the patient passed away ten hours later. Certainty about previous BCG vaccination could not be reached either through medical records or through relative testimonies. The main autopsy findings are summarized below.
Macroscopic findings
A diffuse micro-petechial rash on the abdominal wall was observed. The examination of the cardiovascular system revealed critical stenosis in all coronary arteries: 85% of the lumen was occluded in the left anterior descending artery and the left circumflex artery was almost completely occluded in its central portion. The heart weighed 420 g, and had a left type perfusion. Mild concentric hypertrophy of the left ventricle was present. A broad, whitish, scar in the rear wall of the left ventricle, accompanied with focal wall attenuation was found. Bold atherosclerotic lesions were present in the aorta, and particularly in the bifurcation of the abdominal aorta and also in the common iliac arteries.
The right and left lung weighed 880 g and 860 g respectively, and appeared congestive and edematous. On their pleural surface were exhibited multiple, yellowish nodules of maximum diameter 0.1-0.2 cm. Nodules of the same morphology were also noted during lung dissection. The liver weighed 2180 g with fatty liver appearance. The gallbladder was filled with gallstones.
Focal hyperemia of the bladder mucosa, micro-granular appearance of the kidneys and few adhesions between the viscera of the pelvic region were also observed.
Histological examination
The histological examination of lung parenchyma, revealed multiple caseating and non-caseating epithelioid granulomas, with the presence of Langhans and Touton giant cells (Figs. 1a and 1b) . Diffuse, lymphocytic infiltrates were observed in the pulmonary interstitium. Peripheral emphysema, as well as thickening of alveolar septa were observed. Focally, amorphous eosinophilic material filled the alveolar spaces. Hyperplasia of type II pneumonocytes, and sloughing of alveolar type I pneumonocytes were present in these regions.
The histologic sections from the coronary arteries, showed features of activated atherosclerotic plaques. The microscopic examination of the myocardium, revealed findings of mild cardiac hypertrophy, as well as features of previous ischemic myocardial necrosis and fibrosis in the posterior wall of the left ventricle and in the posterior portion of the intraventricular septum.
Severe, fatty degeneration of the liver parenchyma was evident, along with dense lymphocytic inflammatory infiltrates in the portal frames. Focal destruction of hepatocytes and extension of the inflammatory infiltrate within the hepatic lobules were also present. Tiny lymphocytic aggregates were also observed inside the hepatic lobules. Multiple abscesses with neutrophil granulocytes, parenchymal necrosis as well as multiple non-caseating and caseating epithelioid granulomas not associated with bile ducts were present (Fig. 2) . Reactive hepatocyte regeneration was evident in the form of bi-nucleated hepatocytes.
The kidneys presented findings typical of hypertensive atherosclerotic disease, with chronic inflammatory cells (lymphocytes) in the interstitial tissue. The bladder mucosa and submucosa were moderately infiltrated by lymphocytes, plasma cells and eosinophilic leukocytes. Focally, minute, non-necrotic epithelioid granulomas were present. In one of the few places where the transitional epithelium of the bladder was present, features of hyperplasia with regenerative atypia were evident. These minute granulomas, may be attributed to TUR, as well as BCG immunotherapy, so they are not specific for BCG-osis. Thin sections of the prostate, revealed massive necrosis of the organ confluent necrotic granulomas and epithelioid histiocyte aggregates (Fig. 3) .
Figure 1a
Large caseating granuloma in the lung parenchyma (H&E stain ·200).
Histochemical staining for acid fast bacilli (Ziehl-Neelsen) was performed in sections from the lung and liver parenchyma where granulomas were evident, but proved negative. PCR for mycobacterial bacilli was not performed.
The cause of death was attributed to generalized BCG-osis, on grounds of coronary heart disease and papillary urothelial carcinoma of the bladder treated with BCG immunotherapy. The manner of death was certified as natural.
Discussion
The side effects of BCG intra-vesical immunotherapy are usually mild and short-term, such as abacterial cystitis, dysuria, hematuria, low fever and usually recede without special treatment. 6, 12, 13 They are also called noninfectious or inflammatory side effects in the literature. 12 The major side effects are relatively rare (seen in less than 5% of the patients) 10, [18] [19] and can be divided in early or late ones, depending on whether the patient consulted a physician during or after, a 6 month interval from BCG installation. 19 Besides, adverse effects are stratified as local or bladder related, and systemic. 20 Both of them are more frequent during the immediate period after induction, or in the first semester of the maintenance protocol. 20 There are also side effects nonspecific to BCG, which are related with malpractice during the procedure of transurethral BCG installation. 13 Hepatitis, 21 milliary tuberculosis, 22 systemic granulomatous disease, 21, [23] [24] [25] [26] sepsis, 12,27-28 allergic reactions, 13 and cardiac toxicity have been reported among BCG serious adverse effects. 29 The most serious side effect of BCG immunotherapy is BCG-osis or BCG-itis, which is a regularly associated with traumatic bladder catheterization, 6, 10, 13, 30 subsequent hematogenous dispersion of M. bovis, with multiple organ disfunction 31 and failure. This status may be lethal. 13 If a patient with a history of BCG immunotherapy becomes septic, has fever over 39.5°C or has persistent fever over 38.5°C for more than 24 h, BCG-osis should be suspected. 30, 32 The therapeutic manipulation under these circumstances consists of multi-drug antituberculous scheme, plus antibiotics against gram negative bacteria, and corticosteroids. 6, 13, 33 The mechanism implicated in the above mentioned side effects is a hypersensitivity response, based on the presence of granulomas, frequently in the absence of microorganisms or real active dissemination of M. bovis, which is rather unusual. 27, 34 Furthermore, it must be noted that detection of M. bovis, by means of Ziehl Neelsen stain or PCR reaction in the sputum, blood, transbronchial or bone marrow biopsy material, 27, 35 is usually negative, and so diagnosis is based on histopathological findings and case history. 25 In conclusion, attention must be drawn to the affiliation of nurses, physicians and patients with BCG infusion complications in order to decrease side effects and improve the therapeutic procedure. 18, 24, 25 Although BCG administration is common practice between urologists, usually non urologists have to deal with BCG side effects. 13 Regarding the case presented, none of the above mentioned contra-indications were present according to the clinical records. However, the massive necrosis of the prostate as well as the rapid onset of the disease speaks in favor of a traumatic bladder catheterization during the last BCG instillation. The patient developed an acute, rapidly evolving syndrome with high persistent fever after BCG maintenance infusion. He was eventually hospitalized, with septic shock clinical features, the following day. Although, he received adrenaline, broad spectrum antibiotics and corticoids, he did not recover. The cause of death, BCG-osis was revealed by autopsy findings.
This case stresses the importance of alertness for side effects of BCG immunotherapy. Patients as well as health professionals in general, but also forensic pathologists should be acquainted with its features.
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